Drugs / Retaine
last change Jun 2026 re-read 3 minutes ago

Retaine

Developed for
dry eye syndrome
Investigated by
ORA, Inc. · Ocusoft, Inc.

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02139033 May 2014 dry eye syndrome Ocusoft, Inc. Completed No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2015-03-25 Ocusoft, Inc. Results OCuSOFT® Announces Positive Results from Dry Eye Study with Retaine® ocusoft.com ↗

All press releases naming this drug 12 releases

DateIssuerRelease

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Retaine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02139033 ↗